-
Doctors hope, ultimately, to boost cure rates by combining protease inhibitors with a second drug class called polymerase inhibitors.
FORBES: Magazine Article
-
However, as often happens, evolution has got to work and generated drug-resistant strains of the virus by modifying its protease.
ECONOMIST: Drug testing
-
Protease inhibitors shut down AIDS enzymes by locking onto readily available toeholds, but hep-C's protease is smooth.
FORBES: The Next HIV?
-
These work by binding chemically to that enzyme's active site to inhibit its action. (Protease cuts the raw chain of virus protein produced by a subverted cell into functional molecules.) However, the mechanism is not quite identical.
ECONOMIST: Nanotechnology in biology
-
Schering-Plough research head Thomas Koestler says his company is "pretty excited" by the trial results so far for its hepatitis C protease inhibitor drug boceprevir and plans to share data with regulators soon to discuss next steps.
FORBES: Magazine Article
-
The first clear hint of targeted therapy's potential came in late 2003, when researchers at the German firm Boehringer Ingelheim reported that its hepatitis C protease inhibitor lowered the quantity of virus particles by roughly 99.9% in eight patients in two days of treatment, beating what interferon can accomplish in that time period.
FORBES: Magazine Article